|
Volumn 46, Issue SUPPL. 1, 2005, Pages 46-47
|
Priority of epilepsy research in Asia
|
Author keywords
Asia; Epilepsy; Research
|
Indexed keywords
ANTICONVULSIVE AGENT;
HERBACEOUS AGENT;
VALPROIC ACID;
ASIA;
CLINICAL FEATURE;
CLINICAL RESEARCH;
CONFERENCE PAPER;
DEVELOPING COUNTRY;
EEG ABNORMALITY;
EPILEPSY;
EPILEPTOGENESIS;
FOCAL EPILEPSY;
GENETIC MARKER;
GENETIC RISK;
GRAND MAL EPILEPSY;
GRAND MAL SEIZURE;
HUMAN;
MYOCLONUS EPILEPSY;
PRIORITY JOURNAL;
RURAL POPULATION;
SEIZURE SUSCEPTIBILITY;
SIDE EFFECT;
ASIA;
COST OF ILLNESS;
DELIVERY OF HEALTH CARE;
EPILEPSY;
HEALTH PRIORITIES;
HUMANS;
OCEANIA;
RESEARCH;
|
EID: 14944362664
PISSN: 00139580
EISSN: None
Source Type: Journal
DOI: 10.1111/j.0013-9580.2005.461013.x Document Type: Conference Paper |
Times cited : (10)
|
References (5)
|